I think they need to work on their financing strategy for upcoming US trials and have better SH comms. The science is solid!
AIMO.
Ann: Second Complete Response in ACCENT Pancreatic Cancer Trial, page-9
-
- There are more pages in this discussion • 154 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
24.0¢ |
Change
-0.005(2.04%) |
Mkt cap ! $93.52M | |||
| Open | High | Low | Value | Volume |
| 24.0¢ | 24.0¢ | 23.0¢ | $1.394M | 5.895M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 15 | 580668 | 23.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 24.0¢ | 20109 | 1 |
View Market Depth
| Last trade - 16.10pm 28/07/2025 (20 minute delay) ? |
| ATX (ASX) Chart |